These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 32153391)
21. The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials. Ma H; Huang Y; Cong Z; Wang Y; Jiang W; Gao S; Zhu G J Alzheimers Dis; 2014; 42(3):915-37. PubMed ID: 25024323 [TBL] [Abstract][Full Text] [Related]
22. Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis. De Hert M; Yu W; Detraux J; Sweers K; van Winkel R; Correll CU CNS Drugs; 2012 Sep; 26(9):733-59. PubMed ID: 22900950 [TBL] [Abstract][Full Text] [Related]
23. Sertindole for schizophrenia. Lewis R; Bagnall AM; Leitner M Cochrane Database Syst Rev; 2005 Jul; 2005(3):CD001715. PubMed ID: 16034864 [TBL] [Abstract][Full Text] [Related]
24. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. Sink KM; Holden KF; Yaffe K JAMA; 2005 Feb; 293(5):596-608. PubMed ID: 15687315 [TBL] [Abstract][Full Text] [Related]
25. Subjective Versus Objective Outcomes of Antipsychotics for the Treatment of Neuropsychiatric Symptoms Associated with Dementia. Vredeveld EJ; Hulshof TA; Zuidema SU; Luijendijk HJ CNS Drugs; 2019 Sep; 33(9):933-942. PubMed ID: 31473979 [TBL] [Abstract][Full Text] [Related]
26. Atypical antipsychotics for the treatment of dementia-related behaviors: an update. Daiello LA Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594 [TBL] [Abstract][Full Text] [Related]
28. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. Schneider LS; Dagerman KS; Insel P JAMA; 2005 Oct; 294(15):1934-43. PubMed ID: 16234500 [TBL] [Abstract][Full Text] [Related]
29. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
30. Meta-analysis of the effectiveness of atypical antipsychotics for the treatment of behavioural problems in persons with dementia. Yury CA; Fisher JE Psychother Psychosom; 2007; 76(4):213-8. PubMed ID: 17570959 [TBL] [Abstract][Full Text] [Related]
31. Review of the efficacy of placebo in comparative clinical trials between typical and atypical antipsychotics. Oliveira IR; Nunes PM; Coutinho DM; Sena EP Braz J Psychiatry; 2009 Mar; 31(1):52-6. PubMed ID: 19506777 [TBL] [Abstract][Full Text] [Related]
32. Pharmacological interventions for those who have sexually offended or are at risk of offending. Khan O; Ferriter M; Huband N; Powney MJ; Dennis JA; Duggan C Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD007989. PubMed ID: 25692326 [TBL] [Abstract][Full Text] [Related]
33. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Huhn M; Nikolakopoulou A; Schneider-Thoma J; Krause M; Samara M; Peter N; Arndt T; Bäckers L; Rothe P; Cipriani A; Davis J; Salanti G; Leucht S Lancet; 2019 Sep; 394(10202):939-951. PubMed ID: 31303314 [TBL] [Abstract][Full Text] [Related]
34. Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia. Lee PE; Gill SS; Rochon P Neuropsychiatr Dis Treat; 2006 Dec; 2(4):521-9. PubMed ID: 19412500 [TBL] [Abstract][Full Text] [Related]
35. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074 [TBL] [Abstract][Full Text] [Related]
38. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders. Dold M; Samara MT; Li C; Tardy M; Leucht S Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009831. PubMed ID: 25592299 [TBL] [Abstract][Full Text] [Related]